Psychedelic Spotlight Videos

In today’s episode, Psychedelic Spotlight sits down with the founders of Healing Maps, Cory Jones and Mark Goldhar. Healing Maps is a new company which aims to connect depression patients with Ketamine Clinics near them. Once other psychedelic therapies, such as psilocybin therapy and MDMA therapy, become legal, they will expand to those treatments also. […]

In today’s episode, we speak with the leaders of Psilera Bioscience, Chris Witowski and Jackie von Salm, who discuss the revolution in mental health care that psychedelics represent. Psilera is a company focused on using chemistry to find the ideal psycho-active substance. They are also interested in the intersection between consciousness and psychedelics. A couple […]

In this interview, David Flores sits down with Cody Shandraw, the managing partner at Ambria Capital. Ambria Capital is an investment firm which focuses on investing in psychedelic therapies and technologies. In this episode they discuss the psychedelic space in general and Ambria’s approach to investing. Cody acknowledges that many companies in the space will […]

In this interview, Psychedelic Spotlight’s Swati Sharma and Fireside Co-Founder Hanifa Washington discuss why risk reduction, harm reduction and education are essential components for the growth of psychedelics space. Fireside Project is a non-profit psychedelic support line helping people trip better while minimizing the risks and fulfilling the potential of people’s psychedelic experiences. They do […]

In this much anticipated Psychedelic Spotlight podcast, we get to see James from The Psychedelic Investor and Dr. Matthew Johnson of Johns Hopkins University discuss a broad range of topics surrounding psychedelics and their effectiveness as treatments for ailments like tobacco addiction and PTSD. Timestamps: 0:00 – Intro 1:10 – Dr. Johnson’s latest updates on […]

Ronan Levy, founder of Field Trip Health (NASDAQ: FTRP, TSX: FTRP), joins Psychedelic Spotlight’s Swati Sharma to discuss the widening research into psychedelic medicines and how they can be used to help patients in therapy. Field Trip Health is one of the largest providers of psychedelic-assisted therapies globally and has distinguished itself as a leader […]

Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain Injury & Addiction (WESA) Dr. Nazeer is the Founder and President of APS Ketamine/Advanced Psychiatric Solutions, which was recently acquired by Wesana Health (OTC: WSNAF, CSE: WESA), where he now assumes the role of Chief Medical Officer. Dr. Nazeer is nationally known as a spokesperson […]

In this episode James, from The Psychedelic Investor, sits down with Numinus Wellness’ (OTC: NUMIF, TSX.V: NUMI) CEO Payton Nyquvest for the Psychedelic Spotlight Podcast. Numinus is a Psychedelic Medicines company focused on scaling up psychedelic therapy. Perhaps most exciting is their partnership with MAPS, where the two companies are working together to provide MDMA […]

In this interview with Kelsey Ramsden, CEO on MindCure Health (CSE:MCUR) (OTC: MCURF), David Flores, CEO of Global Trac Solutions and Swati Sharma, Media Director of Psychedelic Spotlight, discuss a few interesting topics that surround the psychedelic space. They highlight the importance of women leaders and the fact that more women are coming into a […]

In this episode of the Spotlight On, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues. The conversation then pivots to what Cybin sees as the main issues […]